NFE2L2 and cancer: Since Nrf2 maintains cancer cells in a hybrid state, preventing complete transition (epithelial-to-mesenchymal hybrid transition), as occurs in RCC, cancer cells display higher metastatic potential and develop drug resistance [95,96].